Viatar CTC Solutions Announces Participation in LD Micro Invitational Conference

LOWELL, Mass., May 27, 2015 (GLOBE NEWSWIRE) -- Viatar CTC Solutions, Inc. (OTC Pink:VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that its Chairman and CEO, Ilan Reich, will present a corporate overview at the LD Micro Invitational on June 1, 2015.

The presentation will be webcast live and will be available for access on the Investor Relations section of the corporate website In addition to the live webcast, a replay of the presentation will be archived for 90 days.

Event: LD Micro Invitational
Date: June 1, 2015
Time: 2:00pm PT / 5:00pm ET
Webcast Link:

About Viatar CTC Solutions

Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the Viatar™ Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers.

This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.

About LD Micro

LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Main Event in December. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit

CONTACT: Investor Contact: David Burke The Ruth Group 646-536-7009 dburke@theruthgroup.comSource:Viatar CTC Solutions Inc.